Facilities
Research and Development
“A Group that succeeds in research has every chance of succeeding in the world. Research is our mission, it is the foundation of the pharmaceutical industry, and it is in that area that we must succeed.”
Key facts about Research & Development
- The cost of developing a new medicine is about £550 million, 60% of which is spent in clinical trials
- The full drug development process takes 10-12 years
- Only one or two compounds in 10,000 discovered are eventually authorised for use in patients
- A potential new medicine may be rejected at any stage of the development process on safety, efficacy or quality grounds
GJC Pharmaceutical Pvt Ltd regularly invests more than 25% of its annual turnover in research and development, which is significantly higher than the industry average of 17%.
GJC Pharmaceutical Pvt Ltd Research and Development pipeline is extremely healthy, having the potential to submit several true innovations for licence during the next 10 years.
As a priority, GJC Pharmaceutical Pvt Ltd invests in therapeutic areas where there is a medical need. From a product portfolio focused on Cardiovascular disease, Diabetes and Osteoporosis, GJC Pharmaceutical Pvt Ltd plans to develop new and existing products by 2021 for Type 2 diabetes, hypertension, heart failure, prevention of cardiovascular events, depression and neurodegenerative diseases, oncology and osteoarthritis.
Our manufacturing operations are spread across global. We are capable to manufacture wide range of solid oral doses. We have dedicated manufacturing site for various APIs and Its intermediates.